ETF Holdings Breakdown of AMPH

Stock NameAmphastar P
TickerAMPH(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS03209R1032
LEI54930055TH0ZLSAQMJ38

News associated with AMPH

Hsbc Holdings PLC Boosts Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Hsbc Holdings PLC lifted its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 23.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 8,991 shares of the company’s stock after purchasing an additional 1,707 shares during the quarter. […] - 2025-05-09 08:41:01
First Trust Advisors LP Raises Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
First Trust Advisors LP boosted its stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 350.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 81,129 shares of the company’s stock after purchasing an additional 63,100 shares during the quarter. […] - 2025-05-04 08:30:50
Barclays PLC Acquires 10,334 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Barclays PLC lifted its holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 13.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 84,790 shares of the company’s stock after acquiring an additional 10,334 shares during the period. Barclays PLC’s holdings […] - 2025-04-30 08:12:50
Raymond James Financial Inc. Invests $3.45 Million in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Raymond James Financial Inc. purchased a new stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 92,904 shares of the company’s stock, valued at approximately $3,450,000. Raymond James Financial Inc. owned approximately 0.19% of Amphastar […] - 2025-04-28 08:06:47
Vanguard Group Inc. Has $100.79 Million Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Vanguard Group Inc. increased its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 0.1% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 2,714,628 shares of the company’s stock after acquiring an additional 3,155 shares during the quarter. Vanguard Group Inc. owned 0.06% of Amphastar Pharmaceuticals worth $100,794,000 as of […] - 2025-04-10 07:38:49
American Century Companies Inc. Decreases Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
American Century Companies Inc. lessened its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 26.2% in the fourth quarter, Holdings Channel.com reports. The fund owned 472,017 shares of the company’s stock after selling 167,575 shares during the period. American Century Companies Inc.’s holdings in Amphastar Pharmaceuticals were worth $17,526,000 at the […] - 2025-04-01 08:38:53
Thrivent Financial for Lutherans Cuts Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Thrivent Financial for Lutherans reduced its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 2.8% during the fourth quarter, Holdings Channel reports. The institutional investor owned 28,988 shares of the company’s stock after selling 827 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Amphastar Pharmaceuticals were worth $1,076,000 at […] - 2025-04-01 07:40:47
Victory Capital Management Inc. Sells 155,144 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Victory Capital Management Inc. cut its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 71.0% in the 4th quarter, Holdings Channel.com reports. The fund owned 63,387 shares of the company’s stock after selling 155,144 shares during the period. Victory Capital Management Inc.’s holdings in Amphastar Pharmaceuticals were worth $2,354,000 as of […] - 2025-03-18 07:41:08
AlphaQuest LLC Reduces Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
AlphaQuest LLC reduced its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 35.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,862 shares of the company’s stock after selling 2,724 shares during the period. AlphaQuest […] - 2025-03-17 08:03:06
Smartleaf Asset Management LLC Buys 493 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Smartleaf Asset Management LLC grew its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 222.1% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 715 shares of the company’s stock after purchasing an additional 493 shares during the quarter. Smartleaf Asset Management LLC’s holdings in Amphastar Pharmaceuticals were worth $26,000 […] - 2025-03-13 07:54:49
Assetmark Inc. Decreases Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)
Assetmark Inc. reduced its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 4.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 41,921 shares of the company’s stock after selling 1,985 shares during the period. Assetmark Inc.’s holdings in Amphastar Pharmaceuticals were […] - 2025-03-11 08:20:51
Amphastar Pharmaceuticals (NASDAQ:AMPH) Lowered to “Neutral” Rating by Piper Sandler
Piper Sandler cut shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) from an overweight rating to a neutral rating in a research note issued to investors on Tuesday, Marketbeat reports. They currently have $36.00 price target on the stock, down from their previous price target of $66.00. A number of other equities research analysts also […] - 2025-02-05 08:38:50

AMPH institutional holdings

The following institutional investment holdings of AMPH have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-08 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 27,121USD 668,533
2025-05-08 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 4,143USD 102,125 0.9%
2025-05-08 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 23,282USD 573,901
2025-05-08 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 23,282USD 573,901 0.9%
2025-05-08 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 94USD 2,317
Total =77,922 USD 1,920,777
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.